Dr. Jeffrey Schulman, M.D

NPI: 1275688798
Total Payments
$85,576
2023 Payments
$12,459
Companies
20
Transactions
321

Payment Breakdown by Category

Other$63,092 (73.7%)
Consulting$9,260 (10.8%)
Travel$6,982 (8.2%)
Food & Beverage$6,157 (7.2%)
Education$85.04 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,092 30 73.7%
Consulting Fee $9,260 5 10.8%
Travel and Lodging $6,982 32 8.2%
Food and Beverage $6,157 251 7.2%
Education $85.04 3 0.1%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $30,468 41 $0 (2022)
Corium, LLC $29,870 35 $0 (2023)
Shire North American Group Inc $22,137 70 $0 (2019)
Otsuka America Pharmaceutical, Inc. $686.62 24 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $317.15 24 $0 (2023)
Sunovion Pharmaceuticals Inc. $313.92 27 $0 (2022)
AbbVie Inc. $272.13 21 $0 (2023)
Allergan, Inc. $228.33 10 $0 (2020)
Ironshore Pharmaceuticals Inc. $225.05 8 $0 (2023)
Rhodes Pharmaceuticals L.P. $216.02 16 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $12,459 29 Corium, LLC ($12,053)
2022 $18,248 50 Corium, LLC ($17,817)
2021 $30,227 75 Supernus Pharmaceuticals, Inc. ($29,832)
2020 $166.95 11 Allergan, Inc. ($26.73)
2019 $945.72 52 Otsuka America Pharmaceutical, Inc. ($221.49)
2018 $23,136 87 Shire North American Group Inc ($21,817)
2017 $393.00 17 Shire North American Group Inc ($223.68)

All Payment Transactions

321 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/20/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $29.11 General
Category: NEUROSCIENCE
11/28/2023 Noven Therapeutics, LLC Xelstrym (Drug) Food and Beverage In-kind items and services $18.00 General
Category: ADHD
11/07/2023 Noven Therapeutics, LLC Xelstrym (Drug) Food and Beverage In-kind items and services $19.14 General
Category: ADHD
08/23/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $18.00 General
Category: Neuroscience
07/26/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.24 General
Category: NEUROSCIENCE
07/18/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $16.45 General
Category: Psychology/Psychiatric
06/22/2023 Corium, LLC Azstarys (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,800.00 General
Category: CNS Stimulant for ADHD
06/22/2023 Corium, LLC Azstarys (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: CNS Stimulant for ADHD
06/08/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $121.81 General
Category: CNS Stimulant for ADHD
05/10/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.82 General
Category: NEUROSCIENCE
05/03/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.71 General
Category: PSYCHIATRY
04/26/2023 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.23 General
Category: NEUROSCIENCE
04/24/2023 Corium, LLC Azstarys (Drug) Travel and Lodging In-kind items and services $457.88 General
Category: CNS Stimulant for ADHD
04/13/2023 Corium, LLC Azstarys (Drug) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: CNS Stimulant for ADHD
04/13/2023 Corium, LLC Azstarys (Drug) Consulting Fee Cash or cash equivalent $400.00 General
Category: CNS Stimulant for ADHD
03/23/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $121.81 General
Category: CNS Stimulant for ADHD
03/17/2023 Corium, LLC Azstarys (Drug) Travel and Lodging In-kind items and services $219.89 General
Category: CNS Stimulant for ADHD
03/09/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.14 General
Category: Neuroscience
03/08/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.39 General
Category: NEUROSCIENCE
03/04/2023 Corium, LLC Azstarys (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,800.00 General
Category: CNS Stimulant for ADHD
03/01/2023 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $18.67 General
Category: ADHD
02/15/2023 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $16.20 General
Category: NEUROSCIENCE
02/08/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Education In-kind items and services $43.50 General
Category: Psychology/Psychiatric
02/08/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Education In-kind items and services $35.00 General
Category: Psychology/Psychiatric
01/31/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $19.44 General
Category: Psychology/Psychiatric

About Dr. Jeffrey Schulman, M.D

Dr. Jeffrey Schulman, M.D is a Child & Adolescent Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275688798.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Schulman, M.D has received a total of $85,576 in payments from pharmaceutical and medical device companies, with $12,459 received in 2023. These payments were reported across 321 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($63,092).

Practice Information

  • Specialty Child & Adolescent Psychiatry
  • Location Saint Louis, MO
  • Active Since 01/24/2007
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0804X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1275688798

Products in Payments

  • QELBREE (Drug) $25,657
  • MYDAYIS (Drug) $21,968
  • AZSTARYS (Drug) $17,817
  • Azstarys (Drug) $12,053
  • REXULTI (Drug) $686.62
  • VRAYLAR (Drug) $500.46
  • LATUDA (Drug) $313.92
  • VYVANSE (Drug) $241.20
  • Aptensio XR (Drug) $216.02
  • Adzenys XR-ODT (Drug) $211.09
  • TRINTELLIX (Drug) $207.52
  • Dyanavel XR (Drug) $144.16
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $134.07
  • Auvelity (Drug) $114.39
  • SPRAVATO (Drug) $105.85
  • JORNAY PM (Drug) $90.98
  • INVEGA SUSTENNA (Drug) $81.52
  • ADHANSIA XR (Drug) $45.36
  • Xelstrym (Drug) $37.14
  • CAPLYTA (Drug) $33.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Child & Adolescent Psychiatry Doctors in Saint Louis